MNV
Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

The Math Shows XBI Can Go To $121
Thursday, March 1, 9:41 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Dynavax Technologies Corp Breaks Below 200-Day Moving Average - Notable for DVAX
Thursday, March 1, 12:54 PM ET, by Market News Video Staff

In trading on Thursday, shares of Dynavax Technologies Corp (DVAX) crossed below their 200 day ...

ETF Flows Report for 03/06/2018
Tuesday, March 6, 10:46 AM ET, by Market News Video Staff

.porttr { font-family: Arial; font-size: 12pt; font-weight: bold; height: 24px; } .porttd1 { font-family: Arial; ...

SPDR S&P Biotech ETF Experiences Big Inflow
Tuesday, March 6, 11:06 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, ARRY, LOXO, AVXS Exchange traded funds (ETFs) trade just ...

April 27th Options Now Available For SPDR Series Trust - S&P Biotech ETF (XBI)
Thursday, March 8, 11:08 AM ET, by Market News Video Staff

Investors in SPDR Series Trust - S&P Biotech ETF (XBI) saw new options become available ...

Theravance Inc Breaks Above 200-Day Moving Average - Bullish for THRX

By Market News Video Staff, Thursday, January 10, 4:42 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Thursday, shares of Theravance Inc (THRX) crossed above their 200 day moving average of $23.41, changing hands as high as $23.56 per share. Theravance Inc shares are currently trading up about 3.6% on the day. The chart below shows the one year performance of THRX shares, versus its 200 day moving average:

Theravance Inc 200 Day Moving Average Chart

Looking at the chart above, THRX's low point in its 52 week range is $15.69 per share, with $31.87 as the 52 week high point that compares with a last trade of $23.51.


Special Offer: Find out what Dave Moenning is holding in the ETF Channel Flexible Growth Investment Portfolio with 30 Days Free.

According to the ETF Finder at ETF Channel, THRX makes up 3.18% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading up by about 0.1% on the day Thursday.

See what other ETFs contain THRX
See what other stocks are held by XBI


This Article's Word Cloud:   AMEX   Above   According   Average   Biotech   Channel   Crossing   Dave   Days   ETFs   Find   Finder   Flexible   Free   Growth   Investment   Looking   Moenning   Moving   Offer   Portfolio   SPDR   Special   Start   Stocks   THRX   Their   Theravance   Thursday   about   above   average   below   changing   chart   compares   contain   crossed   currently   hands   high   moving   other   point   share   shares   trading   week   what   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Theravance Inc Breaks Above 200-Day Moving Average - Bullish for THRX | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.